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Introduction {#sec1}
============

Germinal activity persists in the postnatal mammalian brain in specialized niches, namely the dentate gyrus (DG) of the hippocampus and the subventricular zone (SVZ) that surrounds the lateral ventricle (LV). Neural stem cells (NSCs) of the postnatal SVZ divide and give rise to transient amplifying progenitors (TAPs) that generate neuroblasts, which migrate via the rostral migratory stream (RMS) into the olfactory bulb (OB), where they differentiate into neurons ([@bib28]). The SVZ additionally generates glial progenitors that invade the local parenchyma (reviewed in [@bib6]). Recently, accumulating evidence has highlighted the heterogeneous nature of postnatal SVZ in respect to different microdomains generating distinct neural lineages. For example, progenitors of GABAergic neurons are predominantly derived from the lateral SVZ (lSVZ), while the genesis of glutamatergic neuron progenitors is restricted to the dorsal SVZ (dSVZ; [@bib2]; reviewed in [@bib14]). Furthermore, postnatally derived oligodendrocytes are generated from the dSVZ ([@bib24]). This heterogeneity originates from early embryonic development ([@bib15]), and is intrinsically encoded by expression of selected transcription factors (TFs). Therefore, TFs enriched in specific embryonic forebrain regions are persistent in their expression in corresponding microdomains of the postnatal SVZ. Examples of such TFs include EMX1 (pallium; dSVZ), GSX1/2 (lateral and medial ganglionic eminence; lSVZ), and ZIC1/3 (septum; medial SVZ; reviewed in [@bib14]). We recently resolved the transcriptional heterogeneities of different cell populations of the postnatal SVZ, in which an unexpected large number of transcripts (i.e. 1900) were differentially expressed in NSCs and TAPs sorted from defined SVZ microdomains. Intriguingly, most of the transcriptional heterogeneity observed between the dorsal and lateral NSCs (dNSCs and lNSCs) was due to the expression of transcriptional cues. Notably, HOPX was identified with specific abundant expression in dNSCs ([@bib5]). HOPX is a small (73 amino acids) atypical homeodomain protein that lacks DNA binding sites ([@bib11], [@bib36]). *Hopx* expression is minimal at embryonic day 14.5 (E14.5) and peaks around E16.5 with a rostromedial to caudolateral gradient ([@bib30]). HOPX expression has been found in radial astrocytes of the adult DG, while it is described to be consistently absent from the adult SVZ ([@bib45]). Moreover, the expression of HOPX has recently received increasing attention due to its expression in quiescent NSCs, in mature astrocytes in the adult mouse DG ([@bib26]), as well as in outer radial glia (oRG) cells of the developing human brain ([@bib33], [@bib42]). Here, we used various approaches to further investigate the regionalization of the postnatal SVZ and of resident subpopulations of NSCs. In particular, we characterized the spatiotemporal and lineage-specific patterns of HOPX expression in the postnatal SVZ and investigated its potential function in postnatal SVZ germinal activity.

Results {#sec2}
=======

*Hopx* Is Enriched in NSCs of the dSVZ and in Cells of the Astrocytic Lineage {#sec2.1}
-----------------------------------------------------------------------------

In a previous study, we examined the transcriptome of spatially distinct domains of the postnatal SVZ and revealed differential transcriptional networks in region-specific NSCs ([@bib5]). This heterogeneity was explored further by analysis of TFs and transcriptional regulators (termed hereafter as TFs) as well as their association with defined neural lineages. Focusing on TFs only, 112 were differentially expressed between the regionalized subpopulations of NSCs (dNSCs: 61; lNSCs: 51; [Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A--S1C). The expression of TFs enriched dorsally was confirmed by examining *in situ* databases (<http://www.brain-map.org/>), and by immunohistochemistry ([Figures 1](#fig1){ref-type="fig"}C and 1D). Among transcripts enriched in dNSCs ([Figure 1](#fig1){ref-type="fig"}B), 5 out of the top 10 (*NeuroD6*, *Eomes*, *NeuroD1*, *Tbr1*, *Neurog2*) are known major determinants of the glutamatergic neuronal lineage ([@bib35], [@bib20], [@bib9], [@bib49]). In addition, a meta-analysis was performed on publicly available datasets of isolated glial cells and neurons for the characterization of TFs into defined neural lineages ([@bib10]). Interestingly, this analysis revealed that TFs enriched in dNSCs formed at least three clusters corresponding to astroglia (18/61), neurons (15/61), and oligodendroglia (11/61; [Figure 1](#fig1){ref-type="fig"}E). In contrast, lNSCs enriched TFs identified a single large neuronal cluster (42/51), while those of oligodendroglia were relatively fewer (3/51) and the astroglial cluster was absent ([Figure S1](#mmc1){ref-type="supplementary-material"}E). These observations underline the greater diversity of lineages arising from the dSVZ, whereas the lSVZ generates almost exclusively interneurons (reviewed in [@bib14], [@bib6]).Figure 1A Meta-Analysis of TFs Enrichment in dNSCs Highlights Their Association with Distinct Neural Lineages(A) Heatmap showing enrichment of 61 TFs in dNSCs compared with lNSCs (≥1.8-fold and p \< 0.05).(B) Top ten TFs enriched in dNSCs.(C and D): Dorsal enrichment of select transcripts was confirmed using the Allen Brain Atlas for *Eomes* (C) and by immunohistochemistry for HOPX (D).(E) Heatmap of dNSC enriched TFs reveals three clusters corresponding to defined neural lineages: oligodendrocytes (purple, 11/61); astrocytes (yellow, 18/61); neurons (turquoise, 15/61). *Hopx* (highlighted in bold) associates with the astrocytic lineage.(F--H) Confirmation of astroglial lineage-specific enrichment of HOPX by immunohistochemistry. HOPX is largely absent in neuroblasts of the RMS (DCX; F) and oligodendrocytes in the CC (OLIG2; G), but is observed in astrocytes of the CC (GFAP; H, arrows indicate double positive cells).CC, corpus callosum; dNSC, dorsal NSCs; lNSC, lateral NSCs; RMS, rostral migratory stream; OPC, oligodendrocyte precursor cell; OL, oligodendrocyte. Scale bars, 500 μm (C and D) and 25 μm (H).

We then focused our analysis onto HOPX, an atypical homeodomain protein, which was notably enriched in both dNSCs (rank 7; 7-fold enriched in dNSCs) and the astrocytic lineage ([Figures 1](#fig1){ref-type="fig"}A, 1B, 1D, and 1E). Immunodetection of HOPX confirmed that it was not expressed in migrating neuroblasts (DCX^+^) of the RMS nor in OLIG2^+^ oligodendrocytes of the corpus callosum (CC; [Figures 1](#fig1){ref-type="fig"}F and 1G). In contrast, HOPX was expressed by astrocytes in the CC (glial fibrillary acidic protein \[GFAP\]^+^; [Figure 1](#fig1){ref-type="fig"}H). In the dSVZ, HOPX expression was evident in astrocyte-like lineages while absent in the other lineages ([Figures S1](#mmc1){ref-type="supplementary-material"}F--S1H), in agreement with the transcriptional meta-analysis ([Figure 1](#fig1){ref-type="fig"}E). Such an expression pattern supports an early expression of HOPX and its association with the astroglial lineage.

HOPX Expression Reveals Intraregional Heterogeneity within the dSVZ {#sec2.2}
-------------------------------------------------------------------

We next focused our analysis on HOPX expression within the dSVZ. Using two different antibodies, HOPX protein expression was found to be restricted to the dSVZ, while it was consistently absent from its lateral counterpart ([Figure 2](#fig2){ref-type="fig"}A; see also [Figure S2](#mmc1){ref-type="supplementary-material"}). A high HOPX expression was already detectable throughout the dorsal region of the VZ/SVZ at E16. At early postnatal time points (postnatal day 1 \[P1\] and P4), its expression remained high but declined sharply thereafter in the young adult SVZ. Throughout its period of expression, a clear mediolateral gradient persisted, with the highest expression observed in the medial aspects of the dorsal wall and declining in its lateral aspects (i.e., high medial-to-lateral expression), which has not yet been described for any other gene ([Figure 2](#fig2){ref-type="fig"}A).Figure 2HOPX Exhibits a Complex Spatial and Temporal Expression Pattern within the SVZ Where it Labels a Subpopulation of dNSCs(A) Representative micrographs of HOPX expression in coronal sections at E16, P1, P4, P21, and P60 (top panels). Higher magnifications (lower panels) show high expression in the embryo (E16) and at early postnatal stages (P1, P4) and a decline thereafter (P21, P60). A clear medial-to-lateral HOPX expression gradient is apparent in the dSVZ (see also [Figure S2](#mmc1){ref-type="supplementary-material"} for a more complete rostrocaudal overview at P4).(B and C) Analysis of HOPX expression in dNSCs was performed in HES5:EGFP mice (B; n = 3 animals) and after short-term (8 hr) targeted EPO of a pCX-GFP plasmid (C; n = 6 animals). Crops show overlap of HOPX with HES5:EGFP- and GFP-positive cells, respectively, which was more pronounced in the medial than lateral subdomain of the dSVZ (crops and graphs).EPO, electroporation; dSVZ, dorsal SVZ; lSVZ, lateral SVZ; dNSC, dorsal NSC. Error bars represent the SEM. Scale bars in (A) represent 1 mm (overview) and 500 μm (crops). Scale bars in (B) and (C) represent 200 μm (DAPI overview), 100 μm (higher magnification), and 25 μm (crops). ^∗^p \< 0.05;^∗∗∗^p \< 0.001.

To further investigate HOPX expression within dNSCs we used the HES5:EGFP mouse line, which efficiently labels NSCs, as previously reported ([@bib5], [@bib17]). Quantification of HOPX expression in the dSVZ in this mouse line revealed that a large proportion (70.1% ± 5.0%) of EGFP^+^ NSCs expressed HOPX. Due to the notable mediolateral gradient of HOPX expression in the dSVZ, quantifications of EGFP^+^/HOPX^+^ cells were performed in the medial and lateral subdomains. There was a significantly higher overlap in the medial subdomain of the dSVZ (90.9% ± 6.6%; dmSVZ) compared with the lateral subdomain (53.7% ± 6.2%; dlSVZ; [Figure 2](#fig2){ref-type="fig"}B). These results were confirmed by performing electroporations (EPOs) of a GFP-encoding plasmid into the dSVZ of pups, which were sacrificed 8 hr later. This enables labeling of cells in direct contact with the lumen of the ventricle, i.e., those with radial glia (RG) morphology, as previously described ([@bib5], [@bib44]). Similar results were obtained with 76.0% ± 2.4% of the electroporated (GFP^+^) cells expressing HOPX, which were significantly larger in the dorsomedial subdomain compared with its dorsolateral counterpart (93.0% ± 2.4% versus 69.3% ± 3.4%; [Figure 2](#fig2){ref-type="fig"}C).

Taken together, the gradient of HOPX expression in dNSCs demonstrates intraregional NSC heterogeneity within the dSVZ wall and proposes its regulation of NSC identity and fate.

The dSVZ Is Defined by Microdomains with Distinct Lineage Outputs {#sec2.3}
-----------------------------------------------------------------

Both the astrocytic expression of HOPX and its regional enrichment within a subpopulation of dNSCs suggest further transcriptional heterogeneity within the dSVZ microdomains. To test this hypothesis, we took advantage of the HES5:EGFP mice and microdissected the medial and lateral parts of the dSVZ (dmSVZ and dlSVZ, respectively) and isolated the NSCs (dmNSCs and dlNSCs, respectively) based on their EGFP expression, as previously described ([@bib5]). qRT-PCR was performed to compare the expression of lineage-specific markers in regional NSC populations ([Figures 3](#fig3){ref-type="fig"}A and 3B).Figure 3Lineage-Specific Markers Highlight Acquisition of Divergent Cell Fates by NSCs Located in Different dSVZ Subdomains(A and B) Heatmaps show enrichment of transcripts in NSCs of distinct SVZ regions (dmNSCs, dlNSCs, lNSCs) compared with the dorsal environment (dSVZ). Transcripts of stem cell, proliferation, and neurogenesis markers (A; top panel) and selected signaling pathways (A; bottom panel) were analyzed. Selected markers of the astroglial (B; top panel), oligodendroglial (B; middle panel), and neuronal lineage (B; bottom panel) were analyzed. Astrocyte and neuronal markers show regional enrichment in dmNSCs and dlNSCs, respectively, while oligodendroglial markers show partial preference for enrichment in dmNSC. Note that HOPX transcripts were enriched in dmNSCs.(C) Scheme representing the counter gradients of the expression of *Hopx* (red) and astroglial markers (yellow) against the expression of neuronal markers (green) in dNSCs. Oligodendroglial markers (blue) do not show such a clear spatial gradient.(D) dmEPO and dlEPO highlight divergent lineage outputs of the two dorsal subdomains. The scheme shows the orientation of the electrodes for the targeted EPOs at P2 followed by analysis at 14 dpe.(E--G) Representative micrographs of OB sections after dmEPO and dlEPO (E and F). Cell counts of OB neurons indicate that neurogenesis of the dSVZ mainly originates from dlNSCs (G).(H--J) Representative micrographs of LV containing sections after dmEPO and dlEPO. Cells with an astrocytic fate were identified according to their morphology and GFAP expression (H and I, arrows indicate double positive cells). Quantification of astrocytes indicate that astrogenesis of the dSVZ is mainly provided by dmNSCs (J).(K) Graph showing the fractions of astroglial and neuronal progenies from NSCs of these two subdomains. It highlights that dmNSCs are primed for generating astrocytes, whilst neurons are derived from dlNSCs.dpe, days post electroporation; dSVZ, dorsal SVZ; dmNSCs, dorsomedial NSCs; dlNSCs, dorsolateral NSCs; lNSCs, lateral NSCs; EPO, electroporation. Animals: (A) 4--5 per n; (B) dmEPO, n = 4; (B) dlEPO, n = 5. Error bars represent SEM. Scale bars in (F) and (I) represent 200 μm (overviews) and 25 μm (crops), and apply also to (E) and (H). ^∗^p \< 0.05; ^∗∗∗^p \< 0.001; ^∗∗∗∗^p \< 0.0001.

We selected known transcripts enriched in NSCs as well as in defined neural lineages ([@bib5], [@bib10]) and compared their expression levels by qPCR. Measured transcripts were all enriched in NSCs compared with the dSVZ, thereby validating our fluorescence-activated cell sorting strategy. In addition, there was no overall regional enrichment of stem cell markers (*Hes5*, *Egfp*; [@bib8]) and a proliferation marker (*Pcna*) within the different NSC populations, although the neuroblast marker *Dcx* was enriched in lNSCs, consistent with a greater number of neuroblasts generated by this SVZ microdomain ([@bib50]; [Figure 3](#fig3){ref-type="fig"}A, top panel). Markers for the astroglial, oligodendroglial, and neuronal lineages were confirmed using the transcriptional datasets from the Barres group ([@bib10]; [Figure S3](#mmc1){ref-type="supplementary-material"}). Markers that were highly specific to astrocytes (*Aqp4*, *Aldh1l1*, *Fgfr3*, *Id3*), including *Hopx*, were enriched in dmNSCs ([Figure 3](#fig3){ref-type="fig"}B, top panel), and those for oligodendroglial lineage (*Pdgfra*, *Plp1*, *Olig1*, *Olig2*, *Dct*) were partly enriched in dmNSCs but overall more homogeneously distributed ([Figure 3](#fig3){ref-type="fig"}B, middle panel). Finally, transcripts of the neuronal lineage (*Dlx2*, *Sp8*, *Eomes*, *Vax1*, *Ebf1*) were generally enriched in dlNSCs or in lNSCs ([Figure 3](#fig3){ref-type="fig"}B, bottom panel), implying spatial segregation of lineages in the dSVZ. Taken together, *Hopx* and astroglial markers exhibit expression patterns in the dSVZ that are opposite to neuronal markers ([Figure 3](#fig3){ref-type="fig"}C). Interestingly, target genes for morphogens, i.e., WNT and SHH, showed that WNT signaling is homogenously distributed throughout the dorsal wall (*Lef1*, *Tcf7*), whereas *Gli1* is highly expressed in lNSCs ([Figure 3](#fig3){ref-type="fig"}A, bottom panel). Another signaling pathway target gene, *Id3*, used as a readout for bone morphogenetic protein (BMP) signaling, showed very marked enrichment in dmNSCs ([Figure 3](#fig3){ref-type="fig"}B, top panel).

Next, to test whether NSCs harbored by those two subdomains are biased to generate specific neural progenies, we performed targeted EPO of the dmSVZ and dlSVZ ([Figure 3](#fig3){ref-type="fig"}D). At a short time point (i.e., 12 hr), EPO of both microdomains with a GFP-encoding plasmid resulted in efficient GFP expression in numerous RG cells. Accurate spatial targeting was assessed by measuring the GFP fluorescence intensity within 50-μm probes distributed along the mediolateral aspects of the dSVZ at 14 days post-electroporation (dpe) ([Figure S4](#mmc1){ref-type="supplementary-material"}). This confirmed the precise and reliable targeting of NSCs of the dmSVZ and dlSVZ. Both regions had given rise to large cohorts of progenies whose distribution and fate appeared to be strikingly different. Indeed, in agreement with the transcriptional profile of dlNSCs, a large population of GFP^+^ neurons in the OB (93.3 ± 11.1, average number of cells/section) were found following dorsolateral EPO (dlEPO), while those derived from the dorsomedial EPO (dmEPO) remained fewer (11.1 ± 1.8; [Figures 3](#fig3){ref-type="fig"}E--3G). In contrast, the population of GFP^+^ astrocytes in the vicinity of the LV (assessed by morphology and GFAP expression; [Figures 3](#fig3){ref-type="fig"}H and 3I), was substantially larger following dmEPO than dlEPO (34.6.5 ± 6.3 versus 16.5 ± 4.1; [Figure 3](#fig3){ref-type="fig"}J). Taken together, our data reveal that dmNSCs are primed to generate astrocytes (74.9% ± 3.0% astrocytes versus 25.1% ± 3.0% neurons), whilst dlNSCs generate largely olfactory neurons (15.2% ± 3.8% astrocytes versus 84.8% ± 3.8% neurons; [Figure 3](#fig3){ref-type="fig"}K).

Altogether, these findings demonstrate a high degree of heterogeneity within the dSVZ in containing specialized NSC populations that generate either astrocytes or neurons according to their location.

HOPX-Expressing dNSCs Are Biased to Acquire an Astroglial Fate {#sec2.4}
--------------------------------------------------------------

To confirm a direct relationship between HOPX expression and the generation of distinct neural lineages by dNSCs, we fate-mapped HOPX-expressing NSCs. To this end, we co-electroporated an inducible fluorescent plasmid (pFloxpA-DsRed) with an EGFP plasmid (pCX-GFP) in the dSVZ of P1 HOPX^CreERT2^ mice and analyzed brain sections at 7 and 21 dpe ([Figures 4](#fig4){ref-type="fig"}A and 4B). Tamoxifen-mediated activation of the CRE-recombinase in HOPX^+^ NSCs led to DsRed/GFP co-expression (hereafter termed dsRed) in electroporated cells and their progenies, whilst the HOPX^−^ lineage expressed EGFP only ([Figure 4](#fig4){ref-type="fig"}C). Electroporated cell distribution and fate were assessed at both time points on serial sections encompassing the LV and the OB ([Figures 4](#fig4){ref-type="fig"}D and 4E). These results revealed the presence of DsRed^+^ and GFP^+^ cells at both 7 and 21 dpe ([Figure 4](#fig4){ref-type="fig"}F). Remarkably, while the majority of GFP^+^ cells were found in the OB (7 dpe: 66.2% ± 2.1%; 21 dpe: 77.7% ± 2.5%) and acquired the typical morphology of granule neurons, the majority of DsRed^+^ cells remained in close proximity to the dSVZ, i.e., in the CC and the cortex (7 dpe: 64.6% ± 5.6%; 21 dpe: 63.8% ± 6.8%) at both time points ([Figure 4](#fig4){ref-type="fig"}G). The distinct neural fates adopted by HOPX^+^ or HOPX^−^ NSCs were examined by immunolabeling of GFAP in DsRed^+^ and GFP^+^-expressing progenies in the periventricular regions at 21 dpe. This analysis confirmed that the generation of GFAP^+^ astrocytes produced by HOPX-expressing NSCs was approximately twice as large compared with dNSCs that do not express HOPX (59.2% ± 7.1% versus 32.8% ± 4.3%, [Figure 4](#fig4){ref-type="fig"}H). These findings confirm HOPX as a marker for a subpopulation of dNSCs primed for astrogenesis.Figure 4Conditional Fate Mapping Reveals HOPX-Expressing NSCs Are Biased to Generate Astrocytes(A--C) Co-electroporation of a pCX-GFP and an inducible pFloxpA-DsRed plasmid (1:2; A) in HOPX^CreERT2^ mice, allows lineage tracing of HOPX^+^ and HOPX^−^ populations at short term (7 dpe) and long term (21 dpe; B). This approach results in GFP-only progenies from HOPX^−^ NSCs, whilst HOPX^+^ NSCs give rise to dsRED/GFP (termed as DsRed) progenies (C).(D and E) Representative micrographs of an LV (D) and OB (E) section at 21 dpe. Astrocytic fate was assessed according to morphology and GFAP expression (D, crops). Neuronal fates were assessed in the OB according to morphology (E, crops; yellow arrows indicate DsRed/GFP double positive cells).(F) Graph of absolute numbers of recombined cells (red) and GFP^+^ (green) in LV and OB sections at 7 dpe and 21 dpe.(G) Graph showing the fractions of recombined DsRed^+^ and GFP^+^ cells harbored by LV and OB sections at 7 dpe and 21 dpe.(H) Graph showing the fractions of cells derived from recombined DsRed^+^ and GFP^+^ populations exhibiting astrocytic traits at 21 dpe in the vicinity of the LV.dEPO, dorsal electroporation; dpe, days post electroporation; dSVZ, dorsal SVZ; LV, lateral ventricle; NSCs, neural stem cells; OB, olfactory bulb; Tam, tamoxifen. Animals: 7 dpe, n = 5; 21 dpe, n = 4. Error bars represent SEM. Scale bars in (D) represent 100 μm (DAPI overview and fluorescence overview) and 25 μm (crops). Scale bars in (E) represent 500 μm (DAPI overview), 250 μm (fluorescence overview), and 50 μm (crops). ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001; ^∗∗∗∗^p \< 0.0001.

HOPX Does Not Play an Instructive Role in Astroglial Specification of Postnatal dNSCs {#sec2.5}
-------------------------------------------------------------------------------------

To further explore the role of HOPX in regulating lineage specification and maintenance in the postnatal dSVZ, we performed loss- and gain-of-function (LoF and GoF) experiments ([Figure 5](#fig5){ref-type="fig"}A) and analyzed the effects of these manipulations on the expression of the astrocytic markers (GFAP, S100β, and fatty acid binding protein 7 \[FABP7\]) in the progeny of NSCs. For LoF experiments, we used HOPX^LacZ/WT^ knockin mice, in which βGAL expression can be used to identify both HOPX^−/−^ and HOPX^+/−^ cells in homozygous (HOPX^LacZ/LacZ^) and heterozygous (HOPX^WT/LacZ^) mice, respectively, as validated by immunostaining ([Figure S5](#mmc1){ref-type="supplementary-material"}). First, the effects of HOPX loss on astrocytes was analyzed in the CC at P19 ([Figures 5](#fig5){ref-type="fig"}B and 5C). Quantifications of S100β and/or GFAP in βGAL-expressing cells revealed no significant differences in their proportions. The majority of βGAL^+^ cells, in both backgrounds, maintained their astrocyte identity, as revealed by their expression of GFAP (Het: 86.0% ± 2.3%; knockout \[KO\]: 86.7% ± 3.7%), and minimal changes in S100β expression ([Figure 5](#fig5){ref-type="fig"}C). These results are largely in agreement with those obtained by the GoF approach ([Figure 5](#fig5){ref-type="fig"}D). Indeed, although the raw numbers of GFAP^+^ cells were increased following HOPX GoF ([Figure 5](#fig5){ref-type="fig"}E), only minor and non-significant changes in the fraction of S100β^−^/GFAP^+^ cells were observed (increase from 40.9% ± 7.1% to 56.5% ± 3.7%), whilst the other two groups (GFAP^−^/S100β^+^ and GFAP^+^/S100β^+^) were slightly decreased ([Figure 5](#fig5){ref-type="fig"}F).Figure 5HOPX LoF and GoF Reveal Minimal Effects on Astroglial Specification(A) Overview of LoF and GoF approaches.(B and C) HOPX KO and heterozygous animals were used to analyze the βGAL^+^ populations at P19 (B). Quantifications in the co-expression of S100β and GFAP within the βGAL population were performed in the CC. No differences in the fractions expressing S100β and/or GFAP were observed after HOPX KO (C).(D--F) GoF experiments were performed by dEPO of pCAG-Cre and pCMV-HOPX plasmids (1:2) into Rosa-EYFP animals. Animals were sacrificed at 19 dpe. Quantifications of YFP^+^ cells and co-expression of S100β and GFAP in the YFP populations were performed in the CC (D, arrows indicate GFAP/YFP double positive cells). Whereas the numbers of the YFP-expressing population were increased after HOPX overexpression, notably the GFAP^+^ fraction (E), no differences in the fractions of electroporated cells expressing S100β and/or GFAP were observed (F).(G--I) dmEPOs of pPB-CAG-EmGFP transposon plasmids were performed in WT and HOPX KO animals to closer investigate the function of HOPX during postnatal astrogenesis. Animals were sacrificed at 21 dpe (G, arrows indicate GFAP/YFP double positive cells). Analysis of EmGFP^+^ cells was performed in the CC and cortex. Although the number of EmGFP^+^ cells were decreased following HOPX KO (H), no change was observed in the fraction of electroporated cells expressing FABP7 and/or GFAP (I).(J--L) To investigate ectopic HOPX expression on astrogenesis in NSCs with a low/absent HOPX expression level, dlEPOs of pCAG-Cre and pCMV-HOPX plasmids (1:2) were performed in Rosa-EYFP animals. Animals were sacrificed at 21 dpe (J, arrows indicate GFAP/YFP double positive cells). Analysis of YFP^+^ cells was performed in the CC and cortex. Neither the number of EmGFP^+^ cells (K), nor the fraction of electroporated cells expressing GFAP and/or BLBP (L) were significantly altered following dorsolateral HOPX GoF.βGAL, β-galactosidase; CC, corpus callosum; dEPO/dmEPO/dlEPO, dorsal/dorsomedial/dorsolateral electroporation; dpe, days post electroporation; Ctrl., control; GoF, gain-of-function; LoF, loss-of-function; KO, knockout; WT, wild-type. Animals: (C) HOPX^+/−^, n = 4; (C) HOPX^−/−^, n = 4; (E and F) dEPO Ctrl., n = 4; (E and F) dEPO GoF, n = 4; (H and I) HOPX^+/+^ dmEPO EmGFP, n = 4; (H and I) HOPX^−/−^ dmEPO EmGFP, n = 4; (K and L) dlEPO Ctrl., n = 4; (K and L) dlEPO GoF, n = 7. Error bars represent SEM. Scale bar, 50 μm. ^∗^p \< 0.05.

To more directly address a role for HOPX in NSC specification, we performed dmEPOs of an emerald green GFP (EmGFP) transposon in an HOPX-deficient context ([Figure 5](#fig5){ref-type="fig"}G) as well as HOPX GoF in dlNSCs ([Figure 5](#fig5){ref-type="fig"}J). EPO of dmNSCs into HOPX-deficient animals was expected to show large effects due to their high endogenous HOPX expression (see [Figures 2](#fig2){ref-type="fig"}B and 2C). Indeed, we detected decreased numbers of EmGFP^+^ progenies in the CC and cortex compared with wild-type ([Figure 5](#fig5){ref-type="fig"}H). No change in the fraction of astrocytes (assessed by glial morphology and GFAP and/or FABP7 expression) was observed ([Figure 5](#fig5){ref-type="fig"}I), indicating no changes in cell fates. Conversely, HOPX GoF was performed in dlNSCs, which endogenously express a low level or absent HOPX expression (see [Figures 2](#fig2){ref-type="fig"}B and 2C). HOPX GoF in dlNSCs was not sufficient in driving astrogenesis, as revealed by its marginal effect on GFAP^+^/FABP7^+^ cell numbers or fraction of progenies of electroporated NSCs ([Figures 5](#fig5){ref-type="fig"}K and 5L). This suggests that dlNSCs are unable to be re-specified by HOPX GoF.

Taken together, these results indicate that HOPX does not play an instructive role astrocyte specification. The changes in the densities of GFAP^+^-expressing cells observed following dorsal HOPX GoF rather suggests an indirect effect through regulation of NSC stemness (i.e., persistence or expansion of the NSC population) and/or regulation of GFAP^+^ cell survival.

HOPX Overexpression Regulates Radial Glial Cell Generation and the Germinal Activity of the dSVZ {#sec2.6}
------------------------------------------------------------------------------------------------

These findings discard an instructive role of HOPX in regulating astrogenesis, but rather suggests that manipulation of HOPX alters the pool of fate-mapped cells (see above). To assess whether these effects were related to an expansion and/or persistence of NSCs, we examined the densities of dNSCs following HOPX overexpression as well as the size of their progeny at 4 dpe and 19 dpe, respectively ([Figure 6](#fig6){ref-type="fig"}A). At 4 dpe, a 2-fold increase was evident in the number of YFP^+^ cells presenting a typical radial morphology, while non-RG-like cells were less affected ([Figures 6](#fig6){ref-type="fig"}B and 6C). At this early time point, the fraction of RG cells and non-RG cells were uniformly increased along the medial-to-lateral aspects of the dSVZ ([Figure S6](#mmc1){ref-type="supplementary-material"}). In line with these findings, quantifications confirmed an increased fraction of proliferating (i.e., MCM2^+^) RG cells at 4 dpe in the dSVZ (HOPX GoF: 73.6% ± 4.5%; Ctrl.: 60.6% ± 3.7%; [Figures 6](#fig6){ref-type="fig"}D and 6E). Remarkably, following overexpression, a minority of cells (3.5 ± 1.4 per 50-μm section) that corresponds to approximately 4% of the RG cell population showed distinctive characteristics of oRG ([Figure 6](#fig6){ref-type="fig"}G). oRG are a discrete population of ectopically located RG cells observed during corticogenesis in mice ([@bib47]), and are predominant in humans. These oRG exhibited a long basal process, no apical process, and were located away from the LV surface (most of them were found in the CC) where they maintained expression of NSC markers (i.e., MCM2, SOX2; [Figures 6](#fig6){ref-type="fig"}F and 6H). A substantial fraction of HOPX-induced oRG cells maintained their proliferative potential, as revealed by the co-expression of MCM2 (63.5% ± 19.5%; [Figure 6](#fig6){ref-type="fig"}I).Figure 6HOPX Overexpression Enlarges the Pool of RG Cells, Resulting in Increased Germinal Activity and Appearance of oRG Cells(A) dEPOs of pCAG-Cre and pCMV-HOPX plasmids (1:2) into Rosa-EYFP animals were performed at P2 and quantified at 4 and 19 dpe.(B--E) The YFP^+^ populations were analyzed for RG morphology (B and C) and proliferative potential (D and E, arrows point to YFP/MCM2 double positive cells) at 4 dpe. The population of RG cells, but also non-RG cells were increased following HOPX overexpression (C). A higher fraction of the YFP population was positive for the proliferation marker MCM2 in the GoF group (E).(F--I) Displaced YFP^+^ RG cells with oRG characteristics were frequently observed 4 days following Hopx overexpression. They showed oRG morphology as well as the expression of NSC markers such as SOX2 (F) and MCM2 (H). Arrows highlight triple-positive oRG in both (F) and (H). oRG were quantified for their number per 50-μm section (G) as well as for their co-expression of MCM2 (I).(J--N) The enlarged population of RG cells after HOPX overexpression resulted in increased overall population of YFP^+^ cells at 19 dpe in the OB (J, K, and N) and the dSVZ (L--N).dEPO, dorsal electroporation; dpe, days post electroporation; Ctrl., control; GoF, gain-of-function; CC, corpus callosum; dSVZ, dorsal SVZ; RMS, rostral migratory stream; LV, lateral ventricle. Animals: 4 dpe Ctrl., n = 7; 4 dpe GoF, n = 5; 19 dpe Ctrl., n = 5; 19 dpe GoF, n = 6.Error bars represent SEM. Scale bars in (B), 250 μm (overviews) and 25 μm (crop); scale bars in (D), 25 μm; scale bars in (G) and (H), 1 mm (Dapi overviews), 500 μm (fluorescence overview), and 25 μm (crops); scale bars in (K) and (M), 500 μm (also apply to J and L). ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001; ^∗∗∗∗^p \< 0.0001.

To investigate the later consequences of the HOPX related expansion of RG/oRG cells, we quantified the number of YFP^+^ cells in the dSVZ, RMS, and OB ([Figures 6](#fig6){ref-type="fig"}J--6N) at 19 dpe. At this later time point, an increased number of glial cells in the CC ([Figure 5](#fig5){ref-type="fig"}E) could be detected as well as a significant increase in the number of neurons in the OB ([Figure 6](#fig6){ref-type="fig"}N). Nevertheless, no ectopic neurons were observed in the cortex after HOPX overexpression.

Taken together, these observations demonstrate that HOPX overexpression enlarges the pool of RG cells and induces the ectopic appearance of oRG shortly following EPO, resulting in an increased output of astrocytes and neurons.

Discussion {#sec3}
==========

In this study, the expression hallmarks of TFs that regulate distinct neural lineages were further characterized for their enrichment in specific microdomains of the SVZ. By selecting one of these transcripts, we show that NSCs are spatially segregated and primed to differentiate toward specific neural fates. Our results identify *Hopx* as a gene that unravels further heterogeneity of the dSVZ in mediating aspects of astrogenesis and suggest its association with the emergence of germinal traits observed in higher-order mammals.

The diversity of neural subtypes generated by SVZ-NSCs after birth is much larger than first believed. The concept of SVZ regionalization whereby the genesis of distinct neural lineages are spatially and temporally regulated is being increasingly investigated (reviewed in [@bib14], [@bib6]). NSCs located in SVZ microdomains originate from specific regions of the developing forebrain ([@bib15]), and generate a large diversity of neural cells, including neuronal subtypes, depending on the expression of particular transcriptional programs. Consequently, the expression of TFs directly correlates with the acquisition of defined neural fates, a concept that was explored in the present study. We took advantage of the whole-genome transcriptome of region-specific postnatal NSCs that were recently resolved ([@bib5]). A meta-analysis of TFs expressed in dorsal and lateral NSCs with datasets of isolated forebrain neuronal and glial subpopulations ([@bib10]) highlighted transcriptional networks that correspond to microdomain-specific NSC-derived lineages. Therein, we demonstrate that NSCs are primed to acquire specific fates by the early expression of lineage-specific TFs. Such an early priming is supported by a recent single-cell RNA-sequencing characterization of adult SVZ NSCs ([@bib27]).

Exploring the spatial heterogeneity and restricted nature of NSCs in generating specific neural lineages will be greatly facilitated by the identification of regionalized NSC markers, such as HOPX. Using two separate approaches, we demonstrate that HOPX expression is confined to a subpopulation of dNSCs whilst it is minimally expressed in lNSCs. Additionally, our findings imply an association of HOPX with the astroglial lineage, although not supporting a direct role of HOPX in astrocyte specification. Indeed, HOPX LoF and GoF experiments revealed that it is dispensable during initial astrogenesis from dNSCs, and may modulate differentiation and acquisition of specific astrogenic traits such as GFAP expression, as previously reported elsewhere in other lineages ([@bib32]). Importantly, although HOPX expression is observed in a subpopulation of NSCs that mainly produces astrocytes, it cannot be considered a pan-astrocytic marker. Indeed, HOPX expression is spatially restricted and is therefore likely to be associated with the generation of a subpopulation of astrocytes. Fate-mapping studies revealed that astrocytes are allocated to spatial domains in accordance with their embryonic sites of origin in the ventricular zone ([@bib46]). Furthermore, transcriptomic analysis of astrocytes isolated from various brain regions reveals heterogeneous expression of several astrocytic markers. For instance, HOPX was shown to be enriched in astrocytes of the dorsal forebrain (cortex and hippocampus) and lowly expressed in astrocytes of subcortical regions (thalamus and hypothalamus; [@bib29]). Astrocyte heterogeneity in the CNS has recently been described to influence neuronal synaptogenesis and maturation through secretion of several extracellular matrix proteins ([@bib12]). In addition, the densities of astrocytes vary greatly between brain regions ([@bib1]). The role of HOPX in influencing regional astrocytes properties and/or densities remains to be explored.

Remarkably, postnatal HOPX overexpression enlarged the pool of RG cells and induced the appearance of a small population of ectopically located cells resembling oRG. Whilst oRG cells are rare in mice ([@bib47]), their number increases dramatically in primates in forming a secondary germinal zone (i.e., the outer SVZ, or oSVZ) that contributes to the expansion of upper cortical layers during embryogenesis ([@bib25], [@bib37]). Recently, a number of key studies have reported HOPX expression in human oRG ([@bib33], [@bib42]). Furthermore, ectopic overexpression of the hominoid-specific gene *Tbc1d3* into RG in rodents induces HOPX-expressing oRG that contribute to cortical folding ([@bib22]). In line with these observations, our overexpression results suggest an instructive role for HOPX in oRG cell formation. They further reveal that ectopically generated oRG cells, together with the expansion of the RG population observed following HOPX overexpression, contribute to an increased astrocyte yield adjacent to the LV and concomitant neuronal output in the OB. As discussed above, our results further discard an instructive role of HOPX in astrocyte specification. Indeed, HOPX GoF in dlNSCs, which express low levels of HOPX and are biased to produce neurons, fail to promote astrogenesis. Conversely, loss of HOPX expression in dmNSCs does not impair astrogenesis. Thus, we propose the existence of two largely lineage-restricted dNSC populations, one predisposed toward astrogenesis and the other biased to produce neurons. The concomitant overexpression of HOPX in both populations by dEPO results in their respective expansion and therefore leads to enhanced cellular outputs, i.e., increased astrogenesis and neurogenesis, without affecting their ratio. The mechanisms by which HOPX mediates its functions remain largely unknown. HOPX is an atypical TF that does not bind to DNA directly, but modulates other TFs and/or effectors of signaling pathways at the post-transcriptional level. An interaction of HOPX with SRF has been demonstrated during cardiac development ([@bib36]), but is unlikely to occur in the SVZ where SRF expression remains low (data not shown). A more likely function of HOPX is the modulation of dorsally active signaling pathways, such as the BMP and WNT pathways (see also [@bib3], [@bib7]), which have been demonstrated to fine-tune astrogenesis with neurogenesis during corticogenesis ([@bib18], [@bib31], [@bib43]). Reciprocal signaling between BMP and WNT has been reported in multiple progenitor populations ([@bib19], [@bib23], [@bib34], [@bib38], [@bib16]), and may be integrated by HOPX expression, as recently demonstrated in cardiomyoblasts ([@bib21]). Future studies aimed at manipulating the activity of these two signaling pathways in HOPX KO animals may allow us to address these questions and investigate the role of extrinsic signal integration in lineage fate specification of neighboring populations of NSCs. It is interesting to speculate that other signaling pathways may influence the pattern of HOPX expression and may be implicated in its evolution in primates. Intriguingly, HOPX expression in the mouse SVZ follows the spatiotemporal maturation of ependymal cells, which may gradually restrict RG cell contact with the cerebrospinal fluid ([@bib39]). This, combined with the expression of HOPX in oRG, which lack apical processes in primates, suggests that an unknown cerebrospinal fluid-derived signal may regulate HOPX expression. Such signals might modulate SHH signaling that has been recently identified in regulating oRG cell formation ([@bib48]). In agreement, SHH manipulation in mice results in oRG and gyri formation in the medialmost aspect of the cortex, where high HOPX expression is evident. Expression of HOPX in primate oRG might have evolved from this original pattern of expression for the dual coupling of oRG cells and cortex expansion.

In summary, our work demonstrates that the dSVZ is much more heterogeneous than previously thought in terms of spatial segregation and early priming of NSCs in generating specific neural lineages. The abundant expression of the TF HOPX contributes to the intraregional heterogeneity of the dSVZ in rodents, whilst its overexpression suggests its association with changes observed in germinal regions throughout evolution.

Experimental Procedures {#sec4}
=======================

Animals and Ethics {#sec4.1}
------------------

All animal experiments in Zurich were performed according to the Ethics Committee of the Veterinary Department of the Canton of Zurich (Approval ID 182/2011). Experiments in France were performed in accordance with European requirements 2010/63/UE and have been approved by the Animal Care and Use Committee CELYNE (APAFIS \#187 & 188).

Mice used in this study were: OF1 wild-type (Charles Rivers; France), HES5:EGFP ([@bib8]), HOPX^CreERT2^ ([@bib41]), HOPX^LacZ/WT^ knockin ([@bib36]), and Rosa-EYFP mice ([@bib40]).

Plasmid Preparation and Electroporation {#sec4.2}
---------------------------------------

Plasmids used for electroporation are listed in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Plasmids were prepared and electroporated as previously described ([@bib13]).

Immunohistochemistry {#sec4.3}
--------------------

Mice were sacrificed by an intraperitoneal overdose of pentobarbital followed by perfusion with Ringer\'s Lactate solution and 4% paraformaldehyde (PFA) dissolved in 0.1 M phosphate buffer (PB; pH 7.4). Brains were removed and postfixed for 12--48 hr at 4°C in 4% PFA and sectioned in 50-μm thick coronal serial sections. When necessary, antigen retrieval was performed for 20 min in citrate buffer (pH 6) at 80°C, then cooled for 20 min at room temperature and washed in 0.1 M PB. Immunostaining was performed as previously described ([@bib4]; see also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}).

Fluorescence-Activated Cell Sorting and qPCR {#sec4.4}
--------------------------------------------

HES5:EGFP (with C57BL/6 background) of the age P2--P4 were used for sorting for NSCs as previously described and using the exact same parameters, using 4--5 animals of one litter to generate 1 "n" number ([@bib5]; see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}).

Meta-Analysis of Transcriptional Profiles {#sec4.5}
-----------------------------------------

To generate the lists of TFs that are enriched in dNSCs and lNSCs, we made use of previously published datasets ([@bib5], [@bib10]), accessible on the Gene Expression Omnibus database (GEO: [GSE60905](ncbi-geo:GSE60905){#intref0015} and [GSE9566](ncbi-geo:GSE9566){#intref0020}) and followed a procedure detailed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Quantifications and Statistics {#sec4.6}
------------------------------

Images were acquired using a Leica DM5500 epifluorescent microscope, a Leica TCS SPE II, and a TCS SP5 confocal microscope (Leica Microsystems, Wetzlar, Germany). Images were quantified using ImageJ-win64 or assembled as representative pictures with LAS X, ImageJ, and Photoshop (CS4). Statistical analysis was done with Microsoft Excel 2013 and GraphPad Prism 7. All data are shown as mean ± SEM and statistical significance was calculated using the unpaired t test (in figures ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001).
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